Assessment of salivary adipokines resistin, visfatin, and ghrelin as type 2 diabetes mellitus biomarkers

Mythily Srinivasan, Melinda L. Meadows, Lisa Maxwell

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomarkers for early identification of at-risk individuals and successful prevention. Increase in circulating inflammatory adipokines has been suggested as predictive of T2DM. Human saliva is an easily accessible biospecimen amenable for painless frequent collection and possesses nearly 50% of serum proteome. In this study, we measured the adipokines resistin, visfatin, TNF-α, and ghrelin as markers for T2DM in unstimulated whole saliva (UWS) using specific assay kits. Resistin and visfatin concentrations were significantly higher in T2DM saliva. Although the concentration of acylated or unacylated ghrelin was lower in diabetic saliva, the decrease was not significant. Since resistin and visfatin are biomarkers integral to T2DM pathology, their salivary assessments may receive clinical acceptance.

Original languageEnglish (US)
Article number7463796
JournalBiochemistry Research International
Volume2018
DOIs
StatePublished - Jan 1 2018

Fingerprint

Nicotinamide Phosphoribosyltransferase
Resistin
Ghrelin
Adipokines
Biomarkers
Medical problems
Type 2 Diabetes Mellitus
Saliva
Pathology
Proteome
Hyperglycemia
Assays
Trajectories

ASJC Scopus subject areas

  • Biochemistry

Cite this

Assessment of salivary adipokines resistin, visfatin, and ghrelin as type 2 diabetes mellitus biomarkers. / Srinivasan, Mythily; Meadows, Melinda L.; Maxwell, Lisa.

In: Biochemistry Research International, Vol. 2018, 7463796, 01.01.2018.

Research output: Contribution to journalArticle

@article{331efadf8c6e487495a88fabbe353296,
title = "Assessment of salivary adipokines resistin, visfatin, and ghrelin as type 2 diabetes mellitus biomarkers",
abstract = "Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomarkers for early identification of at-risk individuals and successful prevention. Increase in circulating inflammatory adipokines has been suggested as predictive of T2DM. Human saliva is an easily accessible biospecimen amenable for painless frequent collection and possesses nearly 50{\%} of serum proteome. In this study, we measured the adipokines resistin, visfatin, TNF-α, and ghrelin as markers for T2DM in unstimulated whole saliva (UWS) using specific assay kits. Resistin and visfatin concentrations were significantly higher in T2DM saliva. Although the concentration of acylated or unacylated ghrelin was lower in diabetic saliva, the decrease was not significant. Since resistin and visfatin are biomarkers integral to T2DM pathology, their salivary assessments may receive clinical acceptance.",
author = "Mythily Srinivasan and Meadows, {Melinda L.} and Lisa Maxwell",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/7463796",
language = "English (US)",
volume = "2018",
journal = "Biochemistry Research International",
issn = "2090-2247",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Assessment of salivary adipokines resistin, visfatin, and ghrelin as type 2 diabetes mellitus biomarkers

AU - Srinivasan, Mythily

AU - Meadows, Melinda L.

AU - Maxwell, Lisa

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomarkers for early identification of at-risk individuals and successful prevention. Increase in circulating inflammatory adipokines has been suggested as predictive of T2DM. Human saliva is an easily accessible biospecimen amenable for painless frequent collection and possesses nearly 50% of serum proteome. In this study, we measured the adipokines resistin, visfatin, TNF-α, and ghrelin as markers for T2DM in unstimulated whole saliva (UWS) using specific assay kits. Resistin and visfatin concentrations were significantly higher in T2DM saliva. Although the concentration of acylated or unacylated ghrelin was lower in diabetic saliva, the decrease was not significant. Since resistin and visfatin are biomarkers integral to T2DM pathology, their salivary assessments may receive clinical acceptance.

AB - Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomarkers for early identification of at-risk individuals and successful prevention. Increase in circulating inflammatory adipokines has been suggested as predictive of T2DM. Human saliva is an easily accessible biospecimen amenable for painless frequent collection and possesses nearly 50% of serum proteome. In this study, we measured the adipokines resistin, visfatin, TNF-α, and ghrelin as markers for T2DM in unstimulated whole saliva (UWS) using specific assay kits. Resistin and visfatin concentrations were significantly higher in T2DM saliva. Although the concentration of acylated or unacylated ghrelin was lower in diabetic saliva, the decrease was not significant. Since resistin and visfatin are biomarkers integral to T2DM pathology, their salivary assessments may receive clinical acceptance.

UR - http://www.scopus.com/inward/record.url?scp=85042066439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042066439&partnerID=8YFLogxK

U2 - 10.1155/2018/7463796

DO - 10.1155/2018/7463796

M3 - Article

AN - SCOPUS:85042066439

VL - 2018

JO - Biochemistry Research International

JF - Biochemistry Research International

SN - 2090-2247

M1 - 7463796

ER -